Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficiency) (Parenthetical)

v3.21.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficiency) (Parenthetical) - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Sep. 30, 2021
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficiency)        
Gross proceeds $ 460,989 $ 9,708,038 $ 12,503,750 $ 12,503,750
Issuance costs $ 32,270 $ 433,127 $ 1,898,005 $ 1,000,262